To extend for two years the program for priority review to encourage treatments for rare pediatric diseases.

Summary

This bill amends the Federal Food, Drug, and Cosmetic Act to extend through 2018 the priority review voucher program for treatments for rare pediatric diseases. (A priority review voucher is a transferable voucher that entitles the holder to have a new drug or biological product application acted upon by the Food and Drug Administration within six months.)

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 17 November 2016

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

2. 17 November 2016

   Introduced

   Introduced in House

   Source: IntroReferral

3. 17 November 2016

   Introduced

   Introduced in House

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in House · 17 November 2016 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 17 November 2016

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 17 November 2016

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 17 November 2016

  Open at official source

Sponsors

• Rep. Grayson, Alan [D-FL-9] · D · Sponsor
• · hsif00 · Standing

Related records

• related to → To extend for one year the program for priority review to encourage treatments for rare pediatric diseases.